학술논문

Re-treatment with radium-223: first experience from an international, open-label, phase I/II study in patients with castration-resistant prostate cancer and bone metastases
Document Type
Article
Source
In Annals of Oncology October 2017 28(10):2464-2471
Subject
Language
ISSN
0923-7534